Sensus Healthcare Q2 revenue up 124% to $12.1M; diluted EPS $0.21 vs $(0.02) YoY

Sensus Healthcare, Inc.

2022-Q2 EPS reported $1.17 revenue$22,417,000

Revenue $12.1M, up 124% from $5.4M in Q2 2021; net income $3.5M vs net loss $(0.3M).
Diluted EPS $0.21 vs $(0.02); adjusted EBITDA $4.7M vs $(0.1M).
Gross margin improved to 68.6% from 61.1%; cash and equivalents $33.7M.
Received orders for 10 TransDermal Infusion Systems from Hair Enhancement Centers.
Affirms expectations for continued Q3 growth and full-year profitability.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.